Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?

NCT00688480 is registered in ClinicalTrials.gov with A. D. Struthers as lead sponsor.

NCT NCT00688480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00688480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?
Lead sponsor
A. D. Struthers
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
February 28, 2010
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney disease, left ventricular hypertrophy